drugset / Trial / NCT02502578
Safety Study of CNT-01 in Patients With Idiopathic TGCV
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the safety and to examine the index of the efficacy after repeated dosing of CNT-01 in patients with idiopathic triglyceride deposit cardiomyovasculopathy.
Timeline
- Start
- 2015-09
- Primary completion
- 2016-06
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CNT-01 | Unknown | 500 mg | Oral |